Brophy Gerard

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$24.12M

Insider Activity of Brophy Gerard

The largest sale of all time was on 2021-01-11 and amounted to 594912 shares of Avantor, Inc. for $11.38M.

Biography of Brophy Gerard

No biography is available at this moment.

2023-03-03SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
3,914
0.0006%
$25.00$97,850-16.53%
2023-02-27SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
3,059
0.0005%
$25.00$76,475-13.86%
2023-02-02SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
11,339
0.0017%
$25.06$284,155-15.8%
2022-05-20SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
19,603
0.003%
$31.27$612,986-29.16%
2022-03-01SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
2,027
0.0003%
$34.47$69,871-24.52%
2022-02-23SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
3,059
0.0005%
$33.79$103,364-21.31%
2022-01-05SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
11,551
0.0019%
$38.65$446,446-21.22%
2022-01-03SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
59,418
0.0098%
$40.77$2.42M-26.43%
2021-07-30SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
81,125
0.0137%
$37.24$3.02M-1.73%
2021-05-20SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
19,603
0.0034%
$31.10$609,653+19.22%
2021-02-24SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
6,118
0.0011%
$27.93$170,876+32.96%
2021-02-22SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
39,538
0.0035%
$14.31$565,789+32.63%
2021-01-11SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
594,912
0.0642%
$19.13$11.38M+18.76%
2021-01-06SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
23,018
0.0038%
$27.24$627,010+27.85%
2021-01-04SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
118,836
0.0173%
$23.14$2.75M+31.93%
2020-05-20SaleAvantor, Inc.
AVTR
EVP, Biopharma Production
50,990
0.009%
$17.36$885,186+55.91%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.